UCI researchers announce publication of an open-label clinical trial suggesting that N-acetylglucosamine restores neurological function in Multiple Sclerosis patients
Irvine, CA – Sept. 14, 2023 – UCI researchers have found that a simple sugar, N-acetylglucosamine, reduces multiple inflammation and ...